BRIEF-Graybug And Calcimedica Enter Into Definitive Merger Agreement

Reuters2022-11-22

Nov 21 (Reuters) - Graybug Vision Inc :

* GRAYBUG AND CALCIMEDICA ENTER INTO DEFINITIVE MERGER AGREEMENT

* GRAYBUG- COMBINED COMPANY EXPECTED TO BE FUNDED WITH CASH AND EQUIVALENTS OF APPROX $35 MILLION, WITH AN EXPECTED RUNWAY INTO SECOND HALF OF 2024

* RACHEL LEHENY, PH.D., WILL SERVE AS CHIEF EXECUTIVE OFFICER OF THE COMBINED COMPANY

* PHASE 2B RESULTS IN ACUTE PANCREATITIS FOR LEAD PRODUCT CANDIDATE AUXORA EXPECTED IN SECOND HALF OF 2023

* GRAYBUG VISION- GRAYBUG EQUITY HOLDERS ARE EXPECTED TO COLLECTIVELY OWN ABOUT 29% OF COMBINED COMPANY

Source text for Eikon: Further company coverage:

((Reuters.Brief@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2285077387?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-11-22 07:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2285077387","market":"us","top_or_hot":-1,"title":"BRIEF-Graybug And Calcimedica Enter Into Definitive Merger Agreement","media":"Reuters","content":"<html><body><p>Nov 21 (Reuters) - Graybug Vision Inc   :</p><p>   * GRAYBUG AND CALCIMEDICA ENTER INTO DEFINITIVE MERGER AGREEMENT</p><p>   * GRAYBUG- COMBINED COMPANY  EXPECTED TO BE FUNDED WITH CASH AND EQUIVALENTS OF APPROX $35 MILLION, WITH AN EXPECTED RUNWAY INTO SECOND HALF OF 2024</p><p>   * RACHEL LEHENY, PH.D., WILL SERVE AS CHIEF EXECUTIVE OFFICER OF THE COMBINED COMPANY</p><p>   * PHASE 2B RESULTS IN ACUTE PANCREATITIS FOR LEAD PRODUCT CANDIDATE AUXORA EXPECTED IN SECOND HALF OF 2023</p><p>   * GRAYBUG VISION- GRAYBUG EQUITY HOLDERS ARE EXPECTED TO COLLECTIVELY OWN ABOUT 29% OF COMBINED COMPANY</p><p>Source text for Eikon:    Further company coverage:   </p><p>((Reuters.Brief@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Graybug And Calcimedica Enter Into Definitive Merger Agreement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Graybug And Calcimedica Enter Into Definitive Merger Agreement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-22 07:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nov 21 (Reuters) - Graybug Vision Inc   :   * GRAYBUG AND CALCIMEDICA ENTER INTO DEFINITIVE MERGER AGREEMENT   * GRAYBUG- COMBINED COMPANY  EXPECTED TO BE FUNDED WITH CASH AND EQUIVALENTS OF APPROX $...</p>\n\n<a href=\"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2285077387","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2285077387","pubTimestamp":1669074909,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Nov 21 (Reuters) - Graybug Vision Inc   :   * GRAYBUG AND CALCIMEDICA ENTER INTO DEFINITIVE MERGER A","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"简介-Graybug和Calcimedica达成最终合并协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GRAY":0.9},"content_text":"Nov 21 (Reuters) - Graybug Vision Inc   :   * GRAYBUG AND CALCIMEDICA ENTER INTO DEFINITIVE MERGER AGREEMENT   * GRAYBUG- COMBINED COMPANY  EXPECTED TO BE FUNDED WITH CASH AND EQUIVALENTS OF APPROX $35 MILLION, WITH AN EXPECTED RUNWAY INTO SECOND HALF OF 2024   * RACHEL LEHENY, PH.D., WILL SERVE AS CHIEF EXECUTIVE OFFICER OF THE COMBINED COMPANY   * PHASE 2B RESULTS IN ACUTE PANCREATITIS FOR LEAD PRODUCT CANDIDATE AUXORA EXPECTED IN SECOND HALF OF 2023   * GRAYBUG VISION- GRAYBUG EQUITY HOLDERS ARE EXPECTED TO COLLECTIVELY OWN ABOUT 29% OF COMBINED COMPANYSource text for Eikon:    Further company coverage:   ((Reuters.Brief@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2285077387"}